Stifel Nicolaus Restarts Ocera Therapeutics (OCRX) at Buy

December 30, 2013 7:29 AM EST
Get Alerts OCRX Hot Sheet
Price: $2.18 -7.23%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 31 | New: 25
Trade OCRX Now!
Join SI Premium – FREE
Stifel Nicolaus reinstates Ocera Therapeutics (Nasdaq: OCRX) at Buy and price target of $19.

For an analyst ratings summary and ratings history on Ocera Therapeutics click here. For more ratings news on Ocera Therapeutics click here.

Shares of Ocera Therapeutics closed at $11.70 last Fridy.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst PT Change, New Coverage

Related Entities

Stifel

Add Your Comment